{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "regularMarketChangePercent": 1.4285715, "regularMarketPrice": 106.5, "earningsTimestamp": 1683716340, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.99, "epsForward": 0.34, "epsCurrentYear": -1.46, "priceEpsCurrentYear": -72.945206, "sharesOutstanding": 252552992, "bookValue": 10.75, "fiftyDayAverage": 97.148, "fiftyDayAverageChange": 9.351997, "fiftyDayAverageChangePercent": 0.096265465, "twoHundredDayAverage": 71.89, "twoHundredDayAverageChange": 34.61, "twoHundredDayAverageChangePercent": 0.48142996, "marketCap": 29074288640, "forwardPE": 313.2353, "priceToBook": 9.906977, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1340154000000, "priceHint": 2, "marketState": "POSTPOST", "exchange": "TWO", "shortName": "TAIMED BIOLOGICS INC.", "longName": "TaiMed Biologics Inc.", "messageBoardId": "finmb_90417497", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "regularMarketChange": 1.5, "regularMarketTime": 1684128625, "regularMarketDayHigh": 108.0, "regularMarketDayRange": "101.0 - 108.0", "regularMarketDayLow": 101.0, "regularMarketVolume": 10434362, "regularMarketPreviousClose": 105.0, "bid": 106.0, "ask": 106.5, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 104.0, "averageDailyVolume3Month": 6360625, "averageDailyVolume10Day": 5399300, "fiftyTwoWeekLowChange": 54.3, "fiftyTwoWeekLowChangePercent": 1.0402298, "fiftyTwoWeekRange": "52.2 - 135.0", "fiftyTwoWeekHighChange": -28.5, "fiftyTwoWeekHighChangePercent": -0.21111111, "fiftyTwoWeekLow": 52.2, "fiftyTwoWeekHigh": 135.0, "symbol": "4147.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 607, Ruiguang Road", "address2": "3rd Floor Neihu District", "city": "Taipei", "zip": "11492", "country": "Taiwan", "phone": "886 2 2658 0058", "fax": "886 2 2658 6058", "website": "https://www.taimedbiologics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases. It develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase III clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which completed Phase I clinical trials for treating HIV infections; and TMB-365/TMB-380, a neutralizing HIV-1 antibody. The company was incorporated in 2007 and is headquartered in Taipei, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Chin-Ming  Chang Ph.D.", "title": "Pres & CEO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David D.  Ho M.D.", "age": 69, "title": "Scientific Co-Founder, Chief Scientific Advisor and Board Director", "yearBorn": 1953, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ing-Wen  Tsai Ph.D.", "title": "Co-Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Lan-Bo  Chen Ph.D.", "title": "Co-Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jack  Chen", "title": "CFO & Chief of Corp. Governance", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}